Pfizer begins study of oral drug for prevention of COVID-19

Pfizer begins study of oral drug for prevention of COVID-19

Pfizer said on Monday it has started a large study testing its investigational oral antiviral drug for the prevention of COVID-19 infection among those who have been exposed to the virus.


Share:

Comments

Comentarios de Facebook